Breast Cancer Trial, Not Yet Recruiting NCT06718335 Sponsor: Nie Jianyun Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Not Yet Recruiting

NCT06718335
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Women aged 18 to 75 years who have newly diagnosed breast cancer that is currently being treated.
  • The breast cancer has been confirmed by laboratory testing to be HER2 positive (a specific protein found on cancer cells, confirmed by certain test results).
  • The breast cancer has been confirmed by tissue biopsy and imaging scans to be either early-stage or locally advanced, meaning it has not spread to distant parts of the body.
  • The person has a good general health and activity level, rated 0 or 1 on a standard performance scale used by doctors.
  • The person is planning to have surgery to remove the breast cancer, either by removing just the tumour (breast-conserving surgery) or the whole breast, along with lymph node assessment.
  • Blood tests show the blood cell counts, liver function, kidney function, and other markers are within acceptable ranges as determined by the trial team.
  • Heart scans show the heart is pumping well enough (at least 55% efficiency), and a heart tracing (ECG) shows a normal heart rhythm reading.
  • Women who are not menopausal or have not had surgical sterilisation must agree to use effective contraception during treatment and for at least 7 months after the last dose.
  • The person has voluntarily agreed to take part and has signed a consent form.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with a known allergy to any of the medications used in this trial.
  • People who have previously received cancer treatment or radiation therapy for any cancer, except for certain cured skin or cervical cancers (confirm with trial site).
  • People who have had major surgery unrelated to breast cancer within the past 4 weeks, or who have not fully recovered from such surgery.
  • People whose breast cancer has spread to other parts of the body (stage IV or metastatic).
  • People who are unable to swallow, have a bowel blockage, or have other conditions that would affect the body's ability to take in the trial medication.
  • People with serious heart disease or heart problems that cannot be treated.
  • People with a mental illness or substance abuse problem that would prevent them from cooperating with the trial.
  • Women who are pregnant or breastfeeding.
  • People with severe liver, kidney, or blood system diseases.
  • People considered unsuitable by the researchers, including those with a history of drug abuse; use of blood products, anticoagulant medications, or immune-related medications in the past year; poor ability or willingness to follow the treatment plan; or severe high blood pressure, diabetes, or other conditions the doctor considers unsuitable for participation.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13608815577

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Nie Jianyun
Registry
ClinicalTrials.gov
Start date
30 December 2024
Est. completion
30 December 2027

Primary endpoints

Event Free Survival(EFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov